Zhongqiu Q. Lin

107 Yanjiang West Road
Guangzhou, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 101 publications

Sacituzumab govitecan combined with tislelizumab as second-line therapy for recurrent or metastatic cervical cancer: a case report and literature review.

Sacituzumab govitecan combined with tislelizumab as second-line therapy for recurrent or metastatic cervical cancer: a case report and literature review.

Journal: BMC women's health

Published: March 02, 2026

Laparoscopic radical trachelectomy and pelvic lymphadenectomy without uterine manipulator.

Laparoscopic radical trachelectomy and pelvic lymphadenectomy without uterine manipulator.

Journal: Gynecologic oncology reports

Published: January 04, 2026

Correction: PRKCI mediates radiosensitivity via the Hedgehog/GLI1 pathway in cervical cancer.

Correction: PRKCI mediates radiosensitivity via the Hedgehog/GLI1 pathway in cervical cancer.

Journal: Frontiers in oncology

Published: December 10, 2025

Fuzuloparib with or without apatinib as maintenance therapy in newly diagnosed, advanced ovarian cancer (FZOCUS-1): A multicenter, randomized, double-blind, placebo-controlled phase 3 trial.

Fuzuloparib with or without apatinib as maintenance therapy in newly diagnosed, advanced ovarian cancer (FZOCUS-1): A multicenter, randomized, double-blind, placebo-controlled phase 3 trial.

Journal: CA: a cancer journal for clinicians

Published: September 15, 2025

VISTA+ neutrophils contribute to platinum resistance by suppressing CD8+T cells in high-grade serous ovarian cancer.

VISTA+ neutrophils contribute to platinum resistance by suppressing CD8+T cells in high-grade serous ovarian cancer.

Journal: Cancer immunology research

Published: September 10, 2025

Treatment patterns and prognosis of patients with locally advanced vulvar cancer: a retrospective cohort study of the SEER database and a Chinese multicenter registry.

Treatment patterns and prognosis of patients with locally advanced vulvar cancer: a retrospective cohort study of the SEER database and a Chinese multicenter registry.

Journal: Gynecologic oncology

Published: September 10, 2025

A multicenter, prospective, non-interventional drug intensive monitoring study of olaparib in a large real-world Chinese patient cohort with ovarian cancer (DIM-OC).

A multicenter, prospective, non-interventional drug intensive monitoring study of olaparib in a large real-world Chinese patient cohort with ovarian cancer (DIM-OC).

Journal: Journal of ovarian research

Published: August 12, 2025

Expression and clinical value of EIF3CL in serous ovarian cancer.

Expression and clinical value of EIF3CL in serous ovarian cancer.

Journal: The Journal of international medical research

Published: May 26, 2025

The Forefront of Maintenance Therapy for Newly Diagnosed Advanced Ovarian Cancer in China: A Review of Updated Evidence With PARP Inhibitors.

The Forefront of Maintenance Therapy for Newly Diagnosed Advanced Ovarian Cancer in China: A Review of Updated Evidence With PARP Inhibitors.

Journal: BJOG : an international journal of obstetrics and gynaecology

Published: November 28, 2024

Multicenter study of ovarian cancer score for diagnosing ovarian cancer.

Multicenter study of ovarian cancer score for diagnosing ovarian cancer.

Journal: Gynecologic oncology

Published: October 20, 2024

New prognostic index for neoadjuvant chemotherapy outcome in patients with advanced high-grade serous ovarian cancer.

New prognostic index for neoadjuvant chemotherapy outcome in patients with advanced high-grade serous ovarian cancer.

Journal: BMC cancer

Published: August 08, 2024

Preoperative prediction model of lymph node metastasis in the inguinal and femoral region based on radiomics and artificial intelligence.

Preoperative prediction model of lymph node metastasis in the inguinal and femoral region based on radiomics and artificial intelligence.

Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society

Published: August 01, 2024

Showing 1-12 of 101

Last Updated: 09/26/2026